好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

The Prognostic Value of Quantitative EEG in Patients Undergoing Mechanical Thrombectomy for Acute Ischemic Stroke
Epilepsy/Clinical Neurophysiology (EEG)
P4 - Poster Session 4 (5:30 PM-6:30 PM)
6-016

We aim to validate the prognostic value of quantitative EEG (QEEG) for patients who undergo mechanical thrombectomy for acute ischemic stroke.

Previous work has shown that QEEG measures, specifically the delta/alpha ratio (DAR), correlate with the severity of ischemic stroke as measured by the National Institutes of Health Stroke Scale (NIHSS) (Finnigan & van Putten 2013).  To our knowledge, this has not been validated long-term in patients with acute ischemic stroke who have undergone mechanical thrombectomy.

We collected pilot data from 24 patients (10 women, 14 men, mean age 64 years, 21 anterior circulation strokes, 3 basilar) who underwent mechanical thrombectomy at Grady Memorial Hospital (Atlanta, GA) and who also had an EEG performed during their hospital admission for other clinical indications.  Representative 3-minute clips were created from the recorded EEG.  For each patient, we calculated the difference in the delta-alpha ratio (DAR) between both hemispheres using all 16 standard bipolar channels using the Chronux toolbox (chronux.org) in MATLAB (Natick, MA). Correlations (Spearman R) were made between the inter-hemispheric DAR difference in the acute setting and the patients’ NIHSS and Modified Rankin Scale (MRS) scores upon discharge and 3 months after thrombectomy (SAS, Cary, NC).

In the 21 patients with hemispheric strokes, the hemisphere with the larger DAR correctly identified the laterality of stroke in 6 out of 6 right-sided and 11 out of 15 left-sided strokes (p=0.004, Fisher exact).  The absolute value of the inter-hemispheric DAR difference correlated with the discharge NIHSS (R=0.59, p=0.005) and MRS (R=0.53, p=0.008) and the 90-day NIHSS (R=0.6, p=0.06) and MRS (R=0.56, p=0.004) scores.

In this pilot data, the QEEG measure of delta-alpha ratio identified stroke laterality and correlated with discharge and 90-day NIHSS and MRS scores.  This preliminary data supports the prognostic value of QEEG in ischemic stroke patients who have undergone mechanical thrombectomy.

Authors/Disclosures
Adam Dickey, MD, PhD
PRESENTER
No disclosure on file
No disclosure on file
Matthew C. Agan, MD (Wellstar Medical Group) No disclosure on file
William P. Roche, MD (Neurology Associates, LLP) No disclosure on file
Panayiotis Mitsias, MD (Henry Ford Hospital, Neurology) The institution of Dr. Mitsias has received research support from European Union.
Michael R. Frankel, MD (Emory Univ School of Med/Dept of Neuro) The institution of Dr. Frankel has received research support from Nico Corporation, Inc.
Jonathan Ratcliff The institution of Dr. Ratcliff has received research support from Nico Corporation. The institution of Dr. Ratcliff has received research support from Sense .
No disclosure on file
Raul G. Nogueira, MD (UPMC Stroke Institute) Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus.
Diogo C. Haussen, MD Dr. Haussen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stryker. Dr. Haussen has received stock or an ownership interest from Viz AI.
Ioannis Karakis, MD, FAAN (Emory University) Dr. Karakis has received personal compensation for serving as an employee of Emory University School of Medicine. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Karakis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Karakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epitel. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Karakis has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Hill Ward Henderson.